CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleRevenue is $1.85M, lower than 95% of all stocks globally
- PositionOperating margin is -4859.7%, lower than 95% of its Medical Instruments & Supplies peers (median 11.9%)
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
The statements on file don't all cover the same year: income statement FY2025, balance sheet FY2023, cash-flow statement FY2023. Each figure below is labelled with the year it comes from.
Financials view
Market Capitalization
822.54MUSDvs all stocks (USD)
Revenue (TTM)
1.85MUSDvs all stocks (USD)
Profit Margin
0.00%vs Medical Instruments & Supplies peers
Beta
0.7260xvs all stocks
52-Week Change
181.20%vs all stocks
Market Capitalization
822.54MUSDvs all stocks (USD)
Enterprise Value
543.54MUSDvs all stocks (USD)
Forward P/E
-8.62xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
2.95xvs Medical Instruments & Supplies peers
Enterprise to Revenue
293.65xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
-5.76xvs Medical Instruments & Supplies peers
Profit Margin
0.00%vs Medical Instruments & Supplies peers
Operating Margin
-4859.72%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
-33.99%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-59.21%vs Medical Instruments & Supplies peers
Revenue (TTM)
1.85MUSDvs all stocks (USD)
Revenue per Share (TTM)
0.0380USDUpdated Jul 18, 2026Quarterly Revenue Growth
-11.20%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
1.38MUSDvs all stocks (USD)
EBITDA (TTM)
-94.43MUSDvs all stocks (USD)
Net Income (TTM)
-95.30MUSDvs all stocks (USD)
Operating Cash Flow (TTM)
-84.99MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-52.66MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 18, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
-402.83KUSDFY2023 · Dec 31, 2023EPS (Basic)
-2.55USDFY2025 · Dec 31, 2025EPS (Diluted)
-2.55USDFY2025 · Dec 31, 2025Basic Shares Outstanding
36.91MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
36.91MSharesFY2025 · Dec 31, 2025Operating Cash Flow
-40.18MUSDFY2023 · Dec 31, 2023Free Cash Flow
-42.54MUSDFY2023 · Dec 31, 2023Cash & Cash Equivalents (End of Period)
21.09MUSDFY2023 · Dec 31, 2023Interest Paid
38.47KUSDFY2023 · Dec 31, 2023Starting Profit (CF Statement)
-46.76MUSDFY2023 · Dec 31, 2023Depreciation & Amortization
1.16MUSDFY2023 · Dec 31, 2023Stock-based Compensation
5.76MUSDFY2023 · Dec 31, 2023Other Non-cash Items
101.86KUSDFY2023 · Dec 31, 2023Change in Accounts Receivable (CF)
-345.01KUSDFY2023 · Dec 31, 2023Change in Other Assets/Liabilities
-86.72KUSDFY2023 · Dec 31, 2023Capital Expenditures
-2.36MUSDFY2023 · Dec 31, 2023Net Intangibles (CF)
-6.64KUSDFY2023 · Dec 31, 2023Net Acquisitions
-213.00KUSDFY2023 · Dec 31, 2023Net Investing Cash Flow
-2.58MUSDFY2023 · Dec 31, 2023Long-term Debt Payments
-808.05KUSDFY2023 · Dec 31, 2023Other Financing Charges
-2.68MUSDFY2023 · Dec 31, 2023Net Financing Cash Flow
49.34MUSDFY2023 · Dec 31, 2023Shares Outstanding
97.34MSharesUpdated Jul 18, 2026Float Shares
60.34MSharesUpdated Jul 18, 2026Shares Short
6.15MSharesUpdated Jul 18, 2026Short Ratio
4.16daysvs all stocks
Short % of Shares Outstanding
9.03%vs all stocks
% Held by Insiders
16.47%vs all stocks
% Held by Institutions
66.92%vs all stocks
Total Cash (MRQ)
282.70MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
2.90USDUpdated Jul 18, 2026Total Debt (MRQ)
3.73MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0134xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
20.93xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
2.86USDUpdated Jul 18, 2026Total Assets
30.53MUSDvs all stocks (USD)
Total Current Assets
24.22MUSDFY2023 · Dec 31, 2023Total Liabilities
11.63MUSDFY2023 · Dec 31, 2023Total Non-current Assets
6.31MUSDFY2023 · Dec 31, 2023Total Non-current Liabilities
2.17MUSDFY2023 · Dec 31, 2023Total Current Liabilities
9.46MUSDFY2023 · Dec 31, 2023Cash
13.01MUSDFY2023 · Dec 31, 2023Cash Equivalents
8.01MUSDFY2023 · Dec 31, 2023Cash & Cash Equivalents
21.03MUSDFY2023 · Dec 31, 2023Accounts Receivable
407.56KUSDFY2023 · Dec 31, 2023Inventory
442.35KUSDFY2023 · Dec 31, 2023Accounts Payable
3.14MUSDFY2023 · Dec 31, 2023Short-term Debt
668.92KUSDFY2023 · Dec 31, 2023Other Current Liabilities
922.68KUSDFY2023 · Dec 31, 2023Long-term Debt
926.78KUSDFY2023 · Dec 31, 2023Other Non-current Liabilities
93.84KUSDFY2023 · Dec 31, 2023Common Stock (Book)
217.33MUSDFY2023 · Dec 31, 2023Retained Earnings
-200.10MUSDFY2023 · Dec 31, 2023Total Shareholders' Equity
18.90MUSDvs all stocks (USD)
52-Week Low
2.98USDUpdated Jul 18, 202652-Week High
11.05USDUpdated Jul 18, 202652-Week Change
181.20%vs all stocks
Beta
0.7260xvs all stocks
50-Day MA
8.92USDUpdated Jul 18, 2026200-Day MA
6.17USDUpdated Jul 18, 2026Avg 10-Day Volume
1.23MSharesUpdated Jul 18, 2026Avg 30-Day Volume
1.43MSharesUpdated Jul 18, 2026Diluted EPS (TTM)
-2.25USDUpdated Jul 18, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -4859.7%, lower than 95% of its Medical Instruments & Supplies peers (median 11.9%)Significant
Operating margin: -48.60Industry median: 0.12Industry P5: -0.16Peers compared: 65.00
Return on equity is -59.2%, lower than 95% of its Medical Instruments & Supplies peers (median 5.6%)Significant
Return on equity: -0.59Industry median: 0.06Industry P5: -0.46Peers compared: 65.00
Return on assets is -34%, lower than 95% of its Medical Instruments & Supplies peers (median 4%)Significant
Return on assets: -0.34Industry median: 0.04Industry P5: -0.17Peers compared: 65.00
Current ratio is 20.93×, higher than 95% of its Medical Instruments & Supplies peers (median 2.21×)Significant
Current ratio: 20.93Industry median: 2.21Industry P95: 10.51Peers compared: 65.00
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -0.81
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Revenue is $1.85M, lower than 95% of all stocks globallySignificant
Revenue (USD): 1,851,000Global P5: 30,274,777.221
Companies that share the same coordination system — how they create, deliver, or capture value.
Jiangsu Zhenjiang New Energy Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Maccura Biotechnology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Tianjin Printronics Circuit Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Samhyun Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangsu Amer New Material Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Daewon Cable Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sinopec Oilfield Equipment Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Fujian Longxi Bearing (Group) Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Chengdu Xiling Power Science Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Shandong Chenming Paper Holdings Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule